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ABSTRACT 
Traditional medicines have been used for thousands of years in maintaining 
health as an alternative to or in conjunction with modem medicines. A majority of the 
world's population in developing countries take herbal medicine to meet their health 
needs following low cost traditional beliefs and multiple uses of practice adopted by 
their elders and ancestors. Most of traditional herbal preparations that we know of 
today usually comprise of one or more plants in different formulation. Despite their 
popularity, the active principles, mechanism of action and effectiveness of these 
preparations remain largely unknown. Nevertheless, they are used widely in Malaysia 
and other countries. · 
Many studies have been done to find out the efficacy and side effects of these 
preparations but most studies used crude extracts or a single purified compound. This 
does not give a clear picture of its activities as the herbal/traditional preparations are 
normally concoctions of more than one plant/plant products. It is possible that the 
effects of traditional preparations are a mixture of effects from all the plants used in the 
preparation. During the course of therapy, there is concern for some interaction 
between modem medicine and traditional herbal preparations. 
The aim of this project is to study the effect of two herbal products sold in the 
Malaysian market under the name AIR JAMU PAK TANf"> and FAIZOL UBAT 
BA TUK® on the metabolism of aminopyrine in isolated rat hepatocytes. The influence 
of factors such as age, sex and diseases (diabetes and hypertension) on the effect of 
these herbal products on aminopyrine metabolism were also investigated. Diabetes, 
induced in normal rats using streptozotocin (60 mg/kg, i.v.) and spontaneously 
hypertensive rats (their blood pressure higher than 160 mmHg) were used to investigate 
the effect of diabetes and hypertension on aminopyrine metabolism under the influence 
of these herbal products. In-vitro study was carried out using 6x 103 hepatocytes, 250 
mmoi!L aminopyrine and incubation time of 18 minutes. AIR JAMU PAK TANI<.R' or 
FAIZOL UBA T BA TUK<il' dirutions were added to petri dishes containing aminopyrine, 
hepatocytes and incubation medium with final volume of 10 mi. In the case of in-vivo 
study (FAIZOL UBAT BATUK® only) rats were orally fed with several dilutions of 
FAIZOL UBAT BATUK<R' every 8 hours over a period of one day (acute in-vivo study) 
and over a period of seven days (sub-acute study) before sacrificed. Termination of the 
reaction was done by the addition of 25% ZnS04 solution followed by the addition of 
saturated Ba(OH)2. The absorbance that was measured towards the complex 
3,5-diacetyl-1 ,4-dihydrolutidine from the experiment was used to determine the 
concentration of formaldehyde formed (as metabolite of. aminopyrine) during the 
experiment which can be used later to be determine the activity of the enzyme 
aminopyrine N-demethylase. 
.. 
IV 
To study the molecular mechanism through which these herbal products may 
influence the metabolism of aminopyrine, certain cellular inhibitors/stimulants were 
pre-incubated with the hepatocytes for 15 minutes prior to the final incubation of 
aminopyrine with these herbal products FAIZOL UBAT BATUK® and AIR JAMU 
PAK TANI'm. 
In-vitro study of AIR JAMU PAK T AN100 demonstrated that AIR JAMU PAK 
T ANI® could enhance the N-demethylation of aminopyrine indicating that there is a 
direct effect of AIR JAMU, PAK TANIOi' on liver aminopyrine metabolism. Effect of 
AIR JAMU PAK TAN!® on the aminopyrine metabolism was found to be age, sex and 
disease dependent. Certain second messenger pathways (such as cAMP, cytochrome 
P4501A2, phosphatase, G-proteins, Ca/CaM-dependent protein kinase and protein 
tyrosine kinase) were investigated to see the mechanism through which AIR JAMU 
PAK TANI® could enhance the aminopyrine metabolism. 
Our data demonstrated that the molecular mechanism of AfR JAMU PAK 
T ANI® involve various second messenger pathways. This is not surprising since AIR 
JAMU PAK TANI® consist of more than lO plants and the effect of AIR JAMU PAK 
T ANI® seen is most probably attributed to the summative effects of all the chemical 
components found in the whole preparation. 
In the case of F AIZOL UBA T BA TUK® in-vitro hepatic interaction with 
aminopyrine resulted in the increase in the metabolism of the latter (most probably 
ascribed to the total chemical components which consist of at least six plants or plant 
products). Sex, age and disease factors are found to influence the efTect of FAIZOL 
USA T BA TUKOi1 on aminopyrine metabolism. 
® In-vivo study (acute and sub-acute) of FAIZOL UBAT BATUK may suggest 
that a possible hepatic interaction with aminopyrine does occur inside the body 
resulting in increase or decrease in the metabolism of aminopyrine. This hepatic 
interaction was found to be age, sex and disease dependent. The effect of F AIZOL 
UBA T BA TUKCR.1 on aminopyrine metabolism seen in-vivo but not in-vitro suggest that 
FAIZOL UBAT BATUKO:t1 does not have a direct effect on the liver aminopyrine N-
demethylase activity. It's effect on the latter could be via activation--or inhibition of 
other functioning physiological system. The induction of cytochrome P450 synthesis is 
possible but remain to be investigated. 
Both acute and sub-acute in-vivo studies indicate that F AIZOL UBAT BATUK(R' 
is able to increase phase I aminopyrine metabolism in rat liver. The mechanism through 
which it is mediated may differ if it is orally administrated over a period of one day or 
over a period of seven days. 
Kajian Interaksi llbat-lJbatan Tradisionai-Drug !VIoden Dan 
Pencirian Mekanisme Molekul Didalam Tikus 
ABSTRAK 
v 
Ubatan tradisional telah digunakan beribu-ribu tahun untuk penjagaan kesihatan 
sebagai alternatif atau bersama-sama dengan ubat-ubatan moden. Sebahagian besar 
daripada penduduk dunia di negara-negara membangun menggunakan ubat-ubatan 
tradisional untuk menjaga keperluan kesihatan mereka kerana perbelanjaan kos yang 
rendah dan kegunaan nya yang pelbagai yang telah diamalkan oleh orang-orang tua dan 
keturunan mereka. Sebahagian besar daripada sediaan herba tradisonal yang kita 
ketahui mengandungi satu atau lebih tumbuh-tumbuhan didalam berbagai-bagai 
formulasi. Walaupun ia masyur, prinsipal aktif, mekanisme tindakan dan keberkesanan 
sediaan-sediaan tersebut masih belum diketahui. 
Banyak kajian telah dijalankan untuk mengkaji keberkesanan dan kesan 
sampingan sediaan-sediaan di atas tetapi kebanyakkannya menggunakan ekstrak 
mentah atau bahan-bahan sebatian tulin. lni tidak menggambarkan aktiviti sebenar 
kerana sediaan-sediaan herba!tradisional kebiasaannya adalah campuran Iebih daripada 
satu tumbuhan/produk tumbuhan. Berkemungkinan besar kesan-kesan sediaan 
tradisional ini adalah hasil daripada kesan campuran kesemua tumbuhan-tumbuhan 
didalam sesuatu sediaan. Didalam sesuatu rawatan terdapat kebimbangan berlakunya 
interaksi diantara ubat moden dengan sediaan ubatan tradisional. 
Tujuan projek ini ialah untuk mengkaji kesan dua produk herba yang dijual di 
. 00 00 pasaran d1bawah nama AIR JAMU PAK TANI dan FAIZOL UBAT BATUK-
terhadap metabolisme aminopirin didalam hepatosit tikus terasing. Pengaruh beberapa 
faktor seperti umur, jantina dan penyakit (diabetes dan darah tinggi) keatas kesan 
produk herba tersebut terhadap metabolisme aminopirin juga telah diselidiki. Diabetes 
telah diaruh didalam tikus normal dengan menggunakan streptozotocin (60 mg/kg, i.v.) 
dan tikus SHR (tekanan darah sistolik melebihi 160 mmHg) telah digunakan untuk 
mengkaji kesan diabetes dan darah tinggi terhadap metabolisme aminopirin dibawah 
pengaruh produk herba tersebut. Kajian in-vitro telah d1jalankan menggunakan 6 x 103 
hepatosit, 250 mmol!L aminopirin dan waktu eraman selama 18 minit. Beberapa 
pencairan produk herba di atas telah ditambah kedalam piring petri yang mengandungi 
aminopirin, hepatosit dan medium eraman sehingga I 0 ml isipadu akhir. Didalam 
kajian in-vivo (FAIZOL UBAT BATUK(Kl sahaja) tikus telah diberi beberapa pencairan 
FAIZOL UBAT BATUK01) secara oral setiap 8 jam selama satu hari (kajian in-vivo 
akut) dan selama 7 hari (kajian in-vivo subakut) sebelum dibunuh. Penamatan 
tindakbalas dilakukan dengan tambahan larutan 25% ZnS0.1 dan diikuti dengan 
tambahan Ba(OHh tepu. Absorbans yang diukur untuk .kompleks 3,5-diasetil-1 ,4-
dihidrolutidin daripada asai telah digunakan untuk mencntukan kcpekatan formaldehid 
yang terbentuk (sebagai metabolit aminopirin) sewaktu kajian yang boleh digunakan 
untuk menentukan aktiviti enzim aminopirin N-demetilase. 
VI 
Untuk mengkaji mekanisme molekul produk herba-herba ini mempengaruhi 
metabolisme aminopirin, beberapa bahan perencat/perangsang sel telah dipre-eramkan 
dengan hepatosit selama 15 minit sebelum eraman terakhir aminopirin bersama AIR 
JAMU PAK TANI'H' atau FAIZOL UBAT BATUK'K>. 
Kaj ian in-vitro AIR JAMU PAK T AN!cro menunjukkan bahawa AIR JAMU 
PAK TANI(R1 berupaya meningkatkan N-demetilasi aminopirin mencadangkan kesan 
langsung AIR JAMU PAK TANl® terhadap metabolisme aminiopirin didalam hati. 
Kesan AIR JAMU PAK TAN!® terhadap metabolisme aminopirin didapati bergantung 
kepada umur, jantina dan penyakit. Beberapa lintasan pengutus kedua (seperti cAMP, 
sitokrom P-450 1" 2, fosfatase, G-protein, protein kinase bersandarkan CaJ'Calm dan 
protein tirosin kinase) telah diselidiki untuk mengetahui mekanisme AIR JAMU PAK 
T ANI00 meningkatkan metabolisme aminopi rin. 
Data kami menunjukkan bahawa mekanisme molekul AIR JAMU PAK TANI® 
melibatkan beberapa lintasan pengutus kedua. Ini tidaklah memeranjatkan kerana AIR 
JAMU PAK T ANI® mengandungi lebih daripada 10 tumbuhan dan kesan AIR JAMU 
PAK T ANI® yang dilihat berkemungkinan besar adalah disebabkan oleh j umlah kesan 
kesemua komponen kimia yang wujud didalam sediaan tersebut. 
Berhubung den!:,Tflan kajian in-vitro F AIZOL UBA T BATUK<R1, interaksi hepat 
bersama aminopirin berkeputusan dengan peningkatan metabolisme aminopirin 
(kemungkinan besar disebabkan oleh kesemua komponen kimia daripada sekurang-
kurangnya enam tumbuhan atau produk tumbuhan). Faktor jantina, umur dan penyakit 
didapati mempengaruhi kesan F AJZOL UBA T BA TUK® terhadap metabolisme 
ammopmn. 
Kajian in-vivo (akut dan subakut) FAIZOL UBAT BATUK(R' mencadangkan 
kemungkinan berlakunya interaksi FAIZOL UBA T BA TUK::R> dengan aminopirin 
didalam tubuh menghasilkan peningkatan/penurunan metabolisme aminopirin. 
Interaksi hepar ini didapati bergantung kepada umur, jantina dan penyakit. Kesan 
F AIZOL UBA T BA TUK® terhadap metabolisme aminopirin dapat dilihat in-vivo tetapi 
tidak in-vitro mencadangkan F AIZOL UBA T BA TUK<fl.> tiada kesan langsung terhadap 
aktiviti aminopirin N-demetilase. hepar. Kesannya mungkin mem!iusi pengaktifan atau 
perencatan sistem fisiologi lain yang berfungsi didalam tubuh. Aruhan sintesis 
sitokrom P-450 mungkin berlaku tetapi perlu diselidiki. 
Kedua-dua kajian akut dan subakut menunjukkan FAIZOL UBAT BATUK'R' 
berupaya meningkatkan metabolisrrre fasa I aminopirin didalam hati tikus. Mekanismc 
yang menentukan pengaruh ini berbeza jika FAIZOL UBAT BATUK4il diberi secara 
oral selama satu hari atau tujuh hari. 
... 
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CHAPTER ONE I INTRODUCTION 
1. 0 INTRODUCTION ---
1.1 Introduction To Traditional Medicine and it's Definition 
Much ofthe ancient literatures on traditional medicine and medicinal plants use 
certain technical terms of botany, pharmacology and medicine which may not be 
familiar to the reader. Some confusion has developed over the years in the use and 
misuse of terms describing the practitioners of traditional medicine and the various 
specialists of this art. For example, even as recently as 1976, it was not possible at 
original committee meeting of the African region of the world health to get the agreed 
definition of practitioner. Opinion was divided as to whether the practitioners of this 
type of medicine should be called "traditional healers, or traditional medical 
practitioners". 
A traditional healer can be described as a person who is reco!:,rnized by the 
community in which he lives as competent to provide health care by using vegetable, 
animal, and mineral substances and certain other methods. These methods are based on 
social, cultural, and religious background as well as on the knowledge, attitudes, and 
beliefs that are prevalent in the c<1mmuhity regarding physical, mental, and social well 
being and the causes of disease and disability. There are certain common factors in the 
principles and practices of traditional medicine throughout the world, similarities 
evolved across oceans and mountains before the present era of international 
... 
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communications. Study and knowledge of these common denominators is important, 
not only as to the discovery of their basis and origins, but also in developing traditional 
medicine as an independent discipline in medicine, and ultimately to integration and 
advancement of the science of healing. While there are major fundamental differences, 
for example between the C::hinese, Arab, Indian, African, and Red Indian system of 
traditional medicine, these differences are often retlection of the sociocultural and 
physical environments in which they have evolved; however, the common threads are 
of greater si~:,rnificance. Health is generally considered as a state of harmony between 
various forces within and outside the body, and disease as an imbalance of these forces, 
personal efforts are required to stay healthy and prophylactic measures are used. Role 
of diet and maintenance of social laws and taboos are stressed. Non-physical causes of 
disease are freely acknowledged. Conceptually, ultimate causation and remedies are 
thought to be due to higher intangible forces who have ultimate control in health and 
healing and maintenance of harmony and equilibrium. The above definition is all-
embracing and incorporates all the facets of traditional healer. However, some 
authorities do not agree with certain aspects of this omnibus definition. For example, 
the fact that a true healer has to be recognized by the community to which he belongs 
has been debated. Yet, in most developing countries it is generally true that a 
traditional practitioner is recognized by the community in \vhich he lives as someone to 
whom the people can turn for help on health matters. Other authorities oppose the 
above definition as it would include witch-doctors, diviners, seers, or spiritualists, a 
situation which would make research into the field of traditional medicine almost 
impossible ( Lewis,1981 ). Traditional medicine can be described as the total 
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combination of knowledge and practice, whether explicable or not, used in diagnosing, 
preventing, or eliminating a physical, mental, or social disease and which may rely 
exclusively on past experience and observation handed down from generation to 
generation, verbally or in writing (Sofowara, 1982). Plants have been used as sources of 
medicine for centuries and c~rrently, it is estimated that some 20,000 species are used 
medicinally throughout the world. Every country and region has its own system of 
traditional medicine in which plants feature to a great extent. In the majority of 
countries, particularly in the rural areas of developing countries, plants continue to 
play a major role in primary health care (Phillipson, 1993). 
A Medicinal plant, is any plant which in one or more of its organs, contains 
substances that can be used for therapeutic purposes or which are precursors for the 
synthesis of useful drugs. Herbalist, a term which describes a traditional healer whose 
specialization lies in the use of herbs to treat various ailments. He is expected to be 
highly knowledgeable in the efficacy, toxicity, dosage, and compounding of herbs. 
Bone setter, is a specialist in one aspect of traditional healing, being skilled in the 
ability to treat fractures. He performs his skills without the aid of X-rays and some-
times also undertakes manipulation of joints and massaging. The term "crude drugs of 
natural or biological origin" is used by pharmacists and pharmacologists to describe 
whole plants or parts of plants which have medicinal properties. Medicinal plants 
include the following: plants or plant "parts used medicinally in glacial preparation (e.g. 
decoctions), plants used for extraction of pure substances either for direct medicinal 
use or for the semi-synthesis of medicinal compounds (e.g. semi-synthesis of sex 
hormones from diosgenin), food, spice, and perfumery plants used medicinally, 
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microscopic plants (e.g. fungi, actinomycetes, used for isolation of drugs especially 
antibiotics), fiher plants (e.g. cotton, flax, jute, used for the preparation of surgical 
dressing). It has been recommended by a WHO consultative group that the term 
"vegetable drug" be applied to that part of medicinal plant (leaf, bark, .. etc.) used for 
therapeutic purposes. Such material, which possesses a cellular structure, is referred to 
in pharmacy as an "organized drug", while medicinal agents such as gums, balsams, 
which have no cellular structure, are called "un-organized drug" (Sofowara, 1982). 
However, any manufacturer wishing to introduce a new herbal product into the market 
as a medicine must apply for a license from the Medicines Control Agency (MCA) or 
in Malaysia, the Drug Control Authority (DCA) and must submit detailed 
documentation on the quality, safety, and efficacy of their product. Furthermore, full 
details of manufacturing protocols are required and the products and their production 
processes are subjected to inspection procedures. Subsequently, all medicinal products, 
including herbal products, have been subjected to a review procedure conducted by the 
Committee on Review of Medicines (CRM). Approximately I 000 herbal medicinal 
products containing some 550 herbs have been approved by the CRM (United 
Kingdom) and they now have full product licenses (Phillipson, 1993). 
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1.2 The use of traditional medicine in the world 
In rev1ewmg the current states of traditional medicine, the regional zones 
designated by the World Health Organization (WHO) will be used. According to the 
WHO and other reports, the position up to 1980 was as follows: IN THE AFRICA 
region traditional medicine has become a part of the people's culture even though this 
form of medicine is not as well organized as for example in India and China. Many 
countries in Africa now have a division, department, or task-force on traditional 
medicine, usually attached to their ministries of health. Most African countries now 
have at least a research group investigating medicinal plants. It is noteworthy that a 
number of research institutions on traditional medicine in Africa now have herbalists 
on their statT. IN THE AMERICAN region, more is heard of traditional ~edicine and 
its practitioners in South America and amongst the American Indians than in North 
America and Canada. The latter two countries however, use many drugs of plant origin 
(Sofowara, 1982). In the USA, approximately 50% of laxative preparation contain plant 
ingredients and this market was valued at US$ 331 million during 1980. Health food 
shops in the USA sold herbs worth US$ 360 million during 1981 (Phillipson, 1 993). In 
several countries, traditional midwives are given basic training and are partly or wholly 
incorporated into the health system. IN THE EUROPEAN region of the world, 
apparently there is little use for trad!tionaJ medicine. Many countries disapprove of the 
WHO's promotion of traditional medicine, perhaps because these countries have much 
highly developed health care for their people. And also, middle-level health personnel 
had replaced the traditional healers of this region of the world. For example in Britain, 
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the days of using a concoction of some 20 plants to treat dropsy have long gone, and 
now the active component, digitalis leaf is used in standardized tablet form. Official 
and professional attitudes in Europe towards an extensive use of traditional 
practitioners is to say the least, cautious. It is considered that traditional practitioners 
and their successors should' receive training from the biological and scientific point of 
view. There is no evidence, however, that this is happening any where in Europe. 
However, herbalists and herbal associations do exist in Britain and Sweden (Sofowara, 
1982). The European market for herbal products is annual growing at rapid pace and in 
1990 it was valued at £1,446.7 million with an average growth rate for all member 
states of 13%. The growth rate for over-the-counter products across Europe is 5.7% and 
the value for phannaceuticals in the European market is £69,652 million. Although the 
herbal product market is only 3.5% of pharmaceutical market it is expanding more 
rapidly. In the UK during 1989, the expenditure on garlic pearls was £4 million and on 
ginseng preparation was £3 million. The herbal teas market in the UK has increased 
steadily since 1984 and the predicted value for 1992 was £10 million. It is salutary to 
realize that herbal teas were only introduced into the UK around 1978. The number of 
specialist health food shops increased by 19% between 1987 and 1992 when it was an 
estimated 2,020. In Europe, Germany is the major importer of medicinal products, and 
in 1979 some 28,000 tons of plant material were imported at a value of around US$ 56 
million. In the UK there is a growing interest in Traditional Chinese Medicine (TCM) 
and numerous shops and TCM clinics have opened up businesses in recent years 
(Phillipson, 1993). I~ THE EASTERN l\IEDITERRANEAN region, several 
countries have developed training programs for traditional birth attendants, thus 
r r- enabling them to play more effective role in the maternal and child health services. In 
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several countries, activities have been focused on research on medicinal plants and the 
production of pharmaceuticals from locally available herbs. There is no official 
framework in any country for traditional and modern medicine to collaborate in the 
interest of the patient. IN THE SOlJTH EAST ASIAN region, traditional medicine 
has been integrated into the official health care system and formal as well as informal 
training of practitioners exists. Formalized system of indigenous medicine include 
ayurveda, yoga, unani-tibbi, modified Chinese, and the Amchi system (a tibetan system 
of medicine). Integrated systems go a step beyond the inclusive category, in which the 
modern and traditional are still formally, if not wholly functionally, separate. The 
policy of the WHO is generally to encourage some type of integration to optimize 
health care coverage (David, 1990). Dhungel & Dias, 1988 note both official 
encouragement for integration and fairly frequent eo-use of modern and traditional· 
facilities. It seems, too, that Korea has, since 1980, enacted legislation to combine 
traditional therapeutic methods with modern dia!:,TJlOsis, including research and training 
in traditional medicine. Overall, however, integration is unlikely to be easily achieved 
(Bibeau, 1985). Non-formalized training of practitioners of indigenous medicine also 
exists in this region including that of herbalists, bone setters, practitioners of thaad 
(element system), home remedists, and spiritualists. In India alone there are 500,000 
indigenous medical practitioners and t 15 recognized institutions of indigenous 
medicine of which 98 colleges train exclusively in ayurveda. University departments of 
traditional medicine existed for many years in India, and institutes carrying out 
multidisciplinary research on medicinal plants abound through this region. Medicinal 
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products compounded from herbs are common sight in the drug stores. IN THE 
WESTERN PACIFIC region, the traditional medicine and the use of medicinal plants 
thrives. Traditional Chinese medicine has had several thousands of years of practical 
experience as well as its own theory. Schools and research institutes for traditional 
medicine have long been established. China offers an enviable example of integration 
of traditional medicine and modern medicine and delegations from various countries of 
the world (Nigeria, U.S.A, ... etc) have visited China to study the successful marriage of 
traditional and modern medicine. Many methods have been developed that are 
economical, and easy to apply. Research on medicinal plants and production of 
phytopharmaceuticals is being undertaken in several countries in this region, and 
attempts have been made to compile a regional pharmacopoeia of crude drugs 
(Sofowara, 1982). Present world economic conditions do not permit pharmaceutical 
companies in their obligation for the extremely expensive research on brand new 
drugs. The companies rather would combine the available brands to obtain "new" ones 
with "better and improved" effects. Traditional medicine all over the world might well 
provide us with vast resources in the search of medicine for "brand new drugs" and 
"brand-new ways of therapies" as well (Negara, 1984). Thousands of years ago, 
Chinese prehistoric ancestors have developed and compiled a healing art by the use of 
needles. Based on their logic and their ancient experience, this practice is magical cure 
of so many diseases. Since the disc~very·of acupuncture anesthesia, about half an era 
ago, for even major surgery, acupuncture has drawn the interest of the west. What 
really does acupuncture do ? Medical science attempts to solve the riddle in the 
laboratories and in the clinics, emphasizing on the effect in the central nervous system, 
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especially the neurotransmitters. The results are encouraging, though the final word is 
still unsaid (Negara, 1984). Health food shops are now starting to lose some of their 
business to pharmacies and pharmacy sales of "healthy type" products has increased 
from 17% of the market to 20% (Phillipson, 1993 ). 
1.3 The use of plants in treatment of disease 
1t is reported that some 80% of the world's inhabitants rely chiefly on traditional 
medicines, mainly plant based, for their primary health care needs (Akerele, 1993). 
Some 21,000 species of medicinal plant have been listed for medicinal use (Penso, 
1983) although it has been argued that this is a most conservative estimate and that the 
number of medicinally-used species is probably between 35,000 to 70,000 (Farnsworth 
and Soejarto, 1991 ). The continued use of herbal medicines has been stressed more 
recently by Dr. X. Zhang, medical officer, traditional medicine, WHO (Zhang, 1996), 
\vho has pointed out that because there is a shortage of medical doctors and 
pharmaceutical products, the majority of the population in developing countries still 
rely mainly on traditional practitioners and local m.edicinal plants to satisfy their 
primary health care needs. The popularity of complementary therapies, including the 
use of herbal remedies, is widespread in North America, Europe and Australia. 
Extrapolation of statistics obtained via a questionnaire in the USA indicates that 
possibly some 42.5 million visits were made to herbalists. in 1990 (Eisenberg et a!, 
1993). Furthermore the same survey indicated that 425 million visits would have been 
made to unconventional therapists contrasting with the 388 million visits actually made 
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to primary health care physicians. OTC sales of herbal medicines in the USA and 
Canada reached US $ 860 million in 1990 with an annual growth rate of 15 % (Zhang, 
1996). 
One European company specializing in the extraction of medicinal plant 
(lndena, Milan) extracts some 12,000 metric tones of plant material per annum and 
additionally prepares pure medicinal drugs by direct isolation from plants and by 
semisynthesis. Some 1139 plant extraction are produced commercially as ethical drugs, 
OTC or nutritional supplements for use in Europe, Japan, South Korea and USA 
(Bombardelli, 1996). Among the active ingredients isolated are some 202 pure 
compounds which are used almost entirely as medicinal drugs. In recent years, natural 
products from higher plants have been highlighted as potential sources of new drugs; 
two notably examples being the antimalarial artemisinin from Artemisia annua and the 
anticancer drug taxol from Taxus brev[folia (Phillipson & Bodeker, 1996). 
1.4 Practice of traditional medicine in l\tlalaysia 
Malaysia is a country that treasures its natural forests. These forests are the 
largest source of natural products which can be used for medicinal purpose. Since the 
early years, the Malays have been using plant products such as the leaves, roots, stems, 
and fruits as inf,'Tedients in the preparation of traditional medicine. Plants were used 
primarily for treatment rather than cure. This was bec~use the practitioners of 
traditional medicine diagnosed disease in a very general way, also every tribe and race 
has its own methods or ways of curing the affliction of disease. Traditional medicine 
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has been used since time immemorial and until today, it remains a popular method of 
treatment. In the earlier centuries, the local community held traditional medicine in 
;· very high regard. This is obvious from the respect accorded by the community to the 
r 
'· Bomoh (medicine-man), the Mak bidan (midwife) and also the Mudim (religious man 
who performs circumcision on boys). These practitioners were revered and were 
completely entrusted with the task of dispensing medical care. Malaysia is rich in 
natural resources basic to traditional medicine. 
There are over six thousand species of tropical plants all over the country and in 
Malaysian Peninsula, there are 550 genera containing 1 ,300 species (Zakaria & Mohd, 
1993). Most of these are medicinal plants good for the human use. Malaysia, as an 
agriculture-based country surely has the potential for increasing its produce of 
medicinal and herbal plants. Even the World Health Organization (WHO) lias proposed 
that by the year 2000, the world population should have learnt to adopt all forms of 
medicine, be they traditional or modern, to eliminate their health problems. Recently, 
there has been a resurgence of awareness among Malaysians to revive traditional 
medicine as part of the Malaysian culture. Academicians are now beginning to study 
this particular area more deeply. In this country, Malay traditional medicine has been 
influenced by various elements from foreib'll medicine. This has been brought about by 
the inter-racial interaction since the days of the Malay Malacca Sultanate in the 
fourteenth century. Chinese and In.dian 'immigrants, too, brought with them various 
medicinal plants which grew well in this country. The local Malay traditional medicine 
is actually based on old Indonesian and Arab traditional medicine, which has been 
modified to suit the local and current needs. Malaysia therefore presents a very 
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interesting case study of medical pluralism in an ethnically diverse and rapidly 
modernizing society. It embraces two of the three t,rreat systems of traditional medicine 
(Arabic, Hindu (Ayurvedic) and Chinese), as well as an extensive network of varied 
types of native medical systems (Kuang, 1983). Indeed, as many as 20 000 bomohs 
minister to the health of Malaysians compared with fewer than 2500 physicians (Vuori, 
!982), as many traditional practitioners are readily accessible. In the Malay villages, 
one can easily find a number of traditional medicine practitioners such as Nujum 
(clairvoyant), Bomoh or Dukun, Tok mudim and Mak bidan. Each has, his or her 
respective role and is essential to the life and harmony of the village. For example, Mak 
bidan plays an important role in treating women as well as in advising young ladies. 
She is usually uneducated and not formally trained. She acquires her skills from 
experienced practitioners and through her own experience. In Malay medicine, the 
Mak bidan performs almost similar functions as a· midwife. She carries out important 
nursing tasks, such as delivering baby, advising pregnant mothers before and after 
delivery, advising young ladies on health care and health problems. In Malay traditional 
medicine, various preparation and methods are used in preparing the medicine. These 
medicine are usually chanted over to ensure their potency, and to avoid toxicity 
(Zakaria & Mohd, 1993). 
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1.5 Liver and drug metabolism 
1.5.1 Introduction: 
Liver plays a crucial role in drug metabolism. Blood flow through liver, and its 
biochemical functions vary from person to person. Variation of function of the liver 
would therefore tend to vary drug metabolism (Lahiri, 1989). Cytochrome P-450 
enzymes are important in the biotransformation of compounds that are normally 
involved in intermediary metabolism (i.e. steroids, vitamins and fatty acids) and 
xenobiotic substances that may be intentionally or inadvertently ingested by the host 
(i.e drugs, environmental pollutants, industrial chemicals and natural products). P-450s 
are found in prokaryotes and eukaryotes, in plants as well as animals. Most animal 
tissues contain some P-450, with the exception of striated muscle and erythrocytes, and 
the enzyme appear to be present in several subcellular organnelles. By the mid-1970, 
several P-450 forms had been isolated and substrate specificities were determined 
(lmai & Sato, 1974; Ryan et af, 1975; Haugen et af., 1975; Guengerich, 1977). Since 
then, the primary sequences of some P-450s and their genes have been determined 
(Black & Coon, 1986). First of all, the substrates for P-450s can be divided into two 
classes: compounds endogenous to mammals and exogenous chemicals which are 
ingested advertently or inadvertently (xenobiotics). Microsomal P-450s oxidize a 
number of endogenous substrates, and some of these reactions are recognized as being 
important to the well-being of the organism. Two isolated types of P-450s enzymes 
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have important roles in the formation of eicosanoids with potent biological activities: 
prostacyclin synthase (aorta) and thromboxane synthase (platelets) (Graf et al., 1983; 
Guengerich, 1987). Many chemicals require oxidation to exert biological activity. In 
this regard, electrophilic compounds are sometimes generated which can bind 
irreversibly to cellular macromolecules such as proteins and DNA What is the real 
function of the P-450s ? Clearly the roles of most of the mitochondrial and microsomal 
P-450s in steroidogenic tissues are in the hydroxylation of steroids. Roles for the liver 
microsomal P-450s have been a matter of speculation. However, most of the major P-
450 forms which have been characterized don't have catalytic activities of obvious 
physiological importance. Do changes in the composition of P-450 forms and in their 
catalytic activities have any physiological implications? Early studies showed that 
administration of certain chemicals such as phenobarbital, 3-methyl-cholanthrene, or 
pregnenolone 16a-carbonitrile to animals resulted in increases in level of P-450 
(Conney et a!., 1956; Guengerich, 1 987; Remmer & Merker, 1963; Solymoss et 
a!., 1971 ). Gross toxicities of other chemicals could also be altered by pre-
administration of such inducing agents, and correlations between P-450 levels and 
toxicity were made (Boyd, 1980; Guengerich, 1987). Unfortunately, the chemicals used 
to induce the P-450s have a number of other physiological effects as well, and these 
phenomena cannot always be sorted out. In individuals with impaired rates of 
oxidation, an increased of drug action- may be seen e.g., increased heart rate due to 
nifedipine (Kleinbloesem et a/.,1984) or adverse side effects may result e.g., 
phenacetin methaemoglobinaemia, captopril induced at,rranulocytosis (Oates et 
a!., 1982: Cooper eta!., 1984). These oxidation have all been shown to involve P-450s 
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(Guengerich eta!., 1985; Distlerath & Guengerich, 1987), although the exact basis of 
the deficiency in catalytic activity has not been ascertained. The effects of changes in 
P-450 composition upon normal physiological function are not well understood, except 
in congenital diseases related to anomalies of steroid metabolism such as adrenal c- 2 I 
hvdroxylase deficiency (WHite et al., 1984; Carroll et al., 1985). In humans, very little is 
-' 
known about the importance of the liver microsomal P-450s on normal physiological 
function. P-450Nr appears to be responsible for much of the testosterone and oestradiol 
hydroxylation in human liver (Guengerich et al., 1986). The same human enzyme, P-
450Nf, is responsible for the formation of 6f3-hydroxycortisol (Ged et al., 1985), which 
is excreted in urine and has been used as a clinical marker for P-450 activity (Ohnhaus 
& Park, 1979). The regulation of metabolic processes ultimately depends upon the 
control of enzyme activity (Martin, 1987). It has been shown in a very wide range of 
different cell types that a rise cyclic AMP in response to a hormone produces a rise in 
the activity ofthe cyclic AMP-dependent protein kinase. However, there is, apparently, 
a discrepancy between the basal protein kinase activity and the resting level of cyclic 
AMP in the cell (Martin, 1987). 
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t.5.2 Cytochrome P-450 
Cytochrome P-450 is a hemeprotein containing one molecule of iron-
protoporphyrin IX as its prosthetic group (Omura & Sato, 1964). 1t is readily identified 
by a pronounced absorbance band at 450 nm in the So ret region of the visible spectrum 
when the carbon monoxide adduct of the reduced hemeprotein is formed hence the 
name P-450. This property of cytochrome P-450 is attributed to the presence of a 
thiolate group as a ligand of the hemeprotein (Peisach & Blumberg, 1970). Cytochrome 
P-450 is classified into two general categories, class A represents the type of P-450 that 
require an FAD - containing flavoprotein and an iron - sulfur protein for electron 
transport from reduced pyridine nucleotide (NADPH) to the hemeprotein (Estabrook et 
a!., 1973). This class of P-450 is most frequently found associated with the 
mitochondria of steroid - metabolizing tissues and also is typical of the P-450s 
associated with bacteria (Peterson & Griffin, 1972). The P-450 of class A are usually 
involved in the metabolism of endogenous compound such as cholesterol, 
deoxycorticosterone, or cholecalciferol and generally possess a high degree of substrate 
specificity. The class B types of cytochromes P-450 require an unusual type of 
flavoprotein, which contains both FAD and FMN as prosthetic groups (Vermilion & 
Coon, 1974., Yasukochi & Masters, 1976), for the transfer of reducing equivalents 
from reduced pyridine nucleotide tv the hemeprotein. In general, this class of P-450 is 
found associated with the microsomal fraction of tissue homogenates in close 
association with another hemeprotein, termed cytochrome b5, in some tissue similar 
type of P-450 is associated with the nucleus (Bresnick eta!., 1977). 
(a) Mitochondria 
Reduced Pyridine -----. Flavoprotein ]ron-Sulfur __ _. Cytochrome 
Nucleotide Protein P-450 
(b) Microsomes 
Reduced Pyridine 
i\ucleotide 
-----.Flavoprotein ----------- Cytochrome 
(FMN,FAD) . ·"' P-450 
F\'IN = Flavin Mononucleotide 
FAD = Flavin Adenine Dinucleotide 
.. . 
Cytochrome b5 
Figure 1.1 Two general categories of cytochrome P-450. The specific reduced pyridine 
nucleotide interacting flavoprotein required for the transfer of electron are designated, and the 
role of the iron- sulfur protein is indicated [(a) Estabrook eta!, 1973; (b) Yasukochi & Masters, 
1976]. 
The senes of cytochrome P-450 directed reaction IS concluded when the 
product of substrate oxidation dissociates from cytochrome P-450, thereby reforming 
the ferric hemeprotein. Essentially nothing is known about this reaction although it is 
recognized that it may be of importance during the steady state of drug metabolism. In 
this way, a cycle of substrate binding, reduction, oxygenation, further reduction, 
rearrangement (assisted perhaps by protonation), and product dissociation 
accomplishes the catalytic oxidative transformation of the substrate together with the 
regeneration of cytochrome P-450 in a f<>rm capable of interacting with yet another 
molecule of substrate. Associated with the function of microsomal-bound cytochrome 
P-450 is the operation of other oxidation - reduction reaction· such as those catalyzed by 
the microsomal hemeprotein, cytochrome b5, or a variety of microsomal tlavoproteins. 
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The cytochrome P-450 of mammalian tissues are associated with membrane 
structures, either the endoplasmic reticulum or the mitochondria. Integration of P-450 
and its requisite companion electron transfer proteins into a membrane structure may 
impose limitations on their mode of function and interaction. In addition, since such 
membranes are rich in phospholipids, and most of the substrates metabolized by P-450 
are highly lipophilic, considerable interest has developed on the role of membrane 
structure relative to the _metabolism of xenobiotics (Mitchell & Horning, 1984 ). 
1.5.2.1 Phase I metabolic reactions 
Drugs are generally metabolise in two phases, namely the so-called Phase I 
or 'biotransformation' in which new function groups are introduced to_ the lipophilic 
chemical, and Phase II or 'conjugation' in which syntheses occur by addition of small 
endogenous molecules to the functional groups of the drug or its Phase I metabolites, 
making the molecules less lipophilic, more polar, and more readily excreted from the 
cell. The major group of Phase I metabolic reactions or biotransformation are 
oxygenation or hydroxylation reactions which affect the addition of oxygen to carbon, 
nitrogen or sulphur, N-and 0-dealkylation, and deamination. These hydroxylation 
reactions are catalysed by the mixed function oxidases of the endoplasmic reticulum of 
the I iver and of certain other tissu~s, such as the I ungs and skin (Park, 1978). 
Dealkylation occurs very readily with drugs containing a secondary or tertiary 
amine, an alkoxy group on an alkyl substituted thiol. Tlie alkyl group is lost as the 
corresponding aldehyde. In the examples of N-demethylation, diazepam, lignocaine, 
ephedrine, aminopyrine, morphine, procainamide, thioridazine, chlorpromazine, 
phenothiazine, tamoxifen, ... etc. are converted to N-demethylated of the substrate with 
the loss of formaldehyde. The reaction is considered to occur in two steps. The first 
being hydroxylation of the--methyl group on the nitrogen, and the second a 
decomposition of this intenpediate. 
1.5.2.2 Assay of aminopyrine N-demethylase activity 
N-demethylation of drugs is a common metabolic pathway and usually 
proceeds by initial hydroxylation at the a-carbon atom and subsequent breakdown of 
carbinolamine intermediate liberating formaldehyde (see fig. 4.1 a). The produced 
formaldehyde could be measured, this would yield an appropriate assay for the N-
demethylase activity. It should be noted that both aminopyrine and monomethyl-4-
aminoantipyrine are metabolised by other pathways (including additional 
demethylation reaction) and therefore this particular assay does not reflect the overall 
metabolism of the substrate (Gibson & Skett, 1994 ). However, the aminopyrine assay 
test is a useful marker of liver enzyme, correlates with the activity of the hepatic 
. . 
mixed-function oxidase system. The main attraction of using the aminopyrine assay test 
lies in its simplicity, and aminopyrine had been proposed as a useful test compound for 
the assessment of hepatic function (Park & Kitteringham, 1988). 
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1.5.3 Signal transduction in drug metabolism 
1.5.3.1 General aspects and roles of cyclic A~'IP 
One of the major reasons for the t,'Towth of interest in protein phosphorylation 
was the discovery that cyclic AMP can often stimulate the reaction. Cyclic AMP is, of 
course, the 'secondary messenger' responsible for the control of many metabolic 
processes, and many hormones have been shown to act by increasing the concentration 
of cyclic AMP in the target tissue. The properties and functions of cyclic nucleotides 
will be discussed later but it may be pointed out here that in a number of cases it has 
been found that the action of cyclic AMP is mediated through protein phosphorylation. 
This has caused considerable interest in the mechanism by which cyclic nucleotides 
can stimulate protein kinase activities. Most of enzymes which are more sensitive to 
cyclic AMP than to other cyclic nucleotides by definition are 'type (a1) protein kinases'. 
Some of the enzymes are more sensitive to cyclic GMP. These are referred to as 'type 
(a2) protein kinases'. Type a1 protein kinases respond to other cyclic nucleotides besides 
cyclic AMP but are much more sensitive to cyclic AMP, although at high concentration 
all cyclic nucleotides often give the same stimulation of activity. In general the order of 
sensitivity appears to be: 
Cyclic AMP>Cyclic IMP >Cyclic GMP >Cyclic UMP >Cyclic CMP 
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There are, however, two regions of the cyclic AMP molecule which are vital for 
activity. Any substitution of the 2'- OH group inactivates cyclic AMP. In addition, 
substitution of the exo-NH2 group may cause some loss of activity. 
~ C.X) N . 
Adenosine 3':5'-phosphate (cyclic AM I'). 
Figure 1 .2 The region of the molecule which are important for activating type a1 protein kinase 
are circled. 
It is perhaps too early to state that the dissociation of regulatory and catalytic 
units is the only mechanism by which protein kinases are stimulated by cyclic AMP but 
no other system has yet been demonstrated. The de!:,TTee of stimulation caused by cyclic 
AMP depends on the type of protein used as substrate and also on the source and purity 
of the enzyme. If the enzyme has become partly dissociated during preparation, and 
contains a high proportion of free catalytic units, it will show relatively high activity in 
the absence of cyclic AMP and be only slightly stimulated (Weller, 1979). Very high 
concentrations of cyclic AMP (in the order of 1 mM) generally inhibit type a 1 protein 
kinases despite the fact that lower concentration cause activation. Since such high 
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concentration are, of course, completely unphysiological, this observation is of limited 
interest. It is possible that high concentrations of cyclic AMP compete with ATP. Of 
more interest is the observation that, in the presence of Ca2+ (instead of Mg2+), cyclic 
AMP inhibits rather than stimulates the activity of type a 1 protein kinases. It should be 
emphasised that, because· a hormone or other substance causes an increase in the 
concentration of cyclic AMP in a tissue, this does not mean that all the effects of the 
substance are mediated by cyclic AMP. It is necessary to demonstrate that the effect in 
question is mimicked by cyclic AMP at near-physiological concentration (Weller, 
1979). 
1.5.3.2 Metabolism and function of cyclic AMP 
Cyclic AMP is formed from ATP in a reaction catalyzed by the enzyme 
adeny late cyclase. 
A TP --------------> 3': 5'- cyclic AMP + ppi 
The most important feature of adenylate cyclase is that it can be stimulated by 
certain hormones and other substances, causing an Increase in the cyclic AMP 
concentration in the affected tissue. Cyclic AMP is broken down by hydrolysis to 5'-
AMP in a reaction catalyzed by cyclic nucleotide phosphodiesterase. The activity of 
phosphodiesterases may also be controlled by certain regulatory substances in the cell. 
It should be emphasised that substances can alter cyclic AMP concentration by an 
action on phosphodiesterase activity, as well as by an action on adenylate cyclase, and 
this possibility should never be overlooked in any investigation of the effect of 
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substances on cyclic AMP concentration. The major, if not only, function of cyclic 
AMP is to act as a messenger from a hormone receptor to various cellular sites with 
which it interacts to cause the observed effects ofthe hormone. Not only is cyclic AMP 
a messenger, allowing the hormone to cause an effect in interior parts of the cell which 
doesn't normally reach, but it also amplifies the message. The interaction of a molecule 
of hormone with the receptor on the adenylate cyclase unit allows the synthesis of a 
number of molecules of cyclic AMP, which spread throughout the cell. In addition, 
there is a second system of amplification which involves the interaction of cyclic AMP 
with its target receptor. In a number of cases, cyclic AMP acts by stimulating a protein 
kinase which phosphorylates the target protein, causing a change in its functional 
activity. This is obviously a further amplification of the message. One molecule of 
cyclic AMP interacts with, and activates, one molecule of the first protein kinase [type 
a1 protein kinase], which phosphorylates, and activates, a number of molecules of the 
second protein kinase (phosphorylase kinase), each activate molecule of which 
interacts with, and activates, a number of molecules of the target protein 
(phosphorylase b). This cascade system obviously produces considerable amplification, 
and even more could be obtained if additional protein kinases were intermediate 
between the kinase containing the original cyclic AMP receptor and the final target 
protein (Weller, 1979). 
H=Hormone 
R=Receptor 
AMP= Adenosine monophosphate. 
ATP=Adenosine triphosphate. 
ADP=Adenosine diphosphate. 
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Figure 1.3 The cyclic AMP mediated the signals as a secondary messenger (Martin, 1987) 
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